News

Press Releases

Inflection Biosciences & RCSI enter research collaboration to target Therapy Resistant BC treatment.

Dublin, Ireland, November 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, and...

Inflection Biosciences to Present at Investor Conferences in November 2017

Dublin, Ireland, November 2, 2017 Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...

Inflection Biosciences Announces Pre-clinical Data to be Presented at 2nd EACR-AACR-SIC Special Conf

Dublin, Ireland, June 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...

Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at IWCLL 2017

Dublin, Ireland, May 15th, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...

Inflection Biosciences to Present at Biotech Showcase 2017

Dublin, Ireland, January 4, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...